Somatostatin Positive Neoplastic Cells Present: Clinical Trials

1 trial for Somatostatin Positive Neoplastic Cells Present, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Terminated 1

Follow Somatostatin Positive Neoplastic Cells Present: new trials by email Literature Review of Somatostatin Positive Neoplastic Cells Present trials Research Report on Somatostatin Positive Neoplastic Cells Present

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors
Computed Tomography, Gallium Ga 68-Edotreotide, Positron Emission Tomography - Meningioma, Metastatic Well Differentiated Neuroendocrine Neoplasm
Early Phase 1TerminatedM.D. Anderson Cancer Center42017-05-162021-02-15

Narrower conditions

Meningioma (1)  ·  Multiple Endocrine Neoplasia Type 1 (1)  ·  Neuroendocrine Tumors (1)  ·  von Hippel-Lindau Disease (1)

Broader conditions

Abnormalities, Multiple (1)  ·  Angiomatosis (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Neoplasms (1)  ·  Ciliopathies (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Meningeal Neoplasms (1)  ·  Multiple Endocrine Neoplasia (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)

Interventions

Magnetic Resonance Spectroscopy (1)  ·  gallium Ga 68 dotatate (1)

Sponsors

M.D. Anderson Cancer Center (1)

Countries

United States (1)

Top investigators

Homer A Macapinlac, MD (1)